Published 12 hours ago • loading... • Updated 6 hours ago
What Happens to Heart Health when You Stop Taking GLP-1 Drugs?
Researchers found the risk rose most among people with obesity, while continued treatment averaged nearly three years and stopping averaged just over one.
An Italian cohort study links GLP-1 receptor agonist discontinuation to higher rates of heart attack, stroke, and death in people with type 2 diabetes.